Mr
Andrew
Camenisch

Partner & Patent Attorney

Leeds Office

Telephone. +44(0) 113 233 0100
Mobile. +44(0) 759 502 7396
Email. [email protected]

Experience

Andy is a Partner at HGF with around 15 years’ experience.

He is a UK and European Patent Attorney and specialises in the fields of chemistry and pharmaceuticals.

Over the years, Andy has worked with many start-ups and SMEs, having secured patent protection for their innovations. He has experience of providing support during investment rounds by interacting with investors. As well as SMEs and start-ups, Andy also works closely with the Technology Transfer and Commercialisation Teams in the University of Leeds, the University of Hull and Bradford University acting as their primary point of contact at HGF.

His day-to-day practice involves providing advice and support in identifying and capturing commercially useful patentable subject matter, providing easy-to-digest guidance for how to obtain granted patents in countries around the world, advising on how third party rights might affect commercial decisions and what can be done to mitigate any risks posed by third party rights.

Specialisms

  • Electrochemistry
  • Material science
  • Pharmaceutical technologies

Industries

  • Agrochemicals icon Agrochemicals
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management

Qualifications

Patent Attorney

Chartered (UK)
European


MSCI

MSci in Chemistry

Conferences: 2020

September 24th 2020

Funding for the Future

Speaker

Event details

Conferences: 2019

March 6th 2019

Pharma IPR 2019

Speaker

Event details

March 6th 2019

8th Annual Pharma IPR Conference 2019 - Mumbai

Speaker

Event details

Conferences: 2018

March 7th 2018

Pharma IPR 2018

Speaker

Event details

January 23rd 2018

GIPC 2018

Speaker

Event details

CSR

Andy is the relationship manager for Nexus in Leeds. Nexus is the Incubation Hub situated on the University of Leeds campus. This involves providing seminars and workshops to the tenants at Nexus and in the wider Leeds City Region, offering drop-in sessions to discuss Nexus’ tenants IP strategy and being on hand to provide guidance to the tenants on various IP issues, which is a complex and confusing area of law.

Andy has also run a summer internship programme for undergraduates at the University of Nottingham in both the chemistry team and the engineering team at HGF.

Related News

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.